Finding the Story in the Data | Meet a Scientist
Sridevi Challa, PhD, an OCRA grantee at UT Southwestern, is on the receiving end of some major accolades. She is the lead author of a study that dozens of news … Continued
News
OCRA-Funded Study Identifies Role of Deubiquitinating Enzyme in Ovarian Cancer Progression
OCRA grantee Dr. Sumegha Mitra of Indiana University and colleagues have identified the mechanism by which a specific deubiquitinating enzyme known as UCHL1 promotes the growth of high-grade serous ovarian cancer in … Continued
Groundbreaking Initiative Seeks to Accelerate Development of New Treatments with OCRA’s Support
LOS ANGELES – (BUSINESS WIRE)–Global Coalition for Adaptive Research (GCAR) announces a new clinical trial initiative, Ovarian CanceRxTM. This innovative trial, referred to as an adaptive platform trial, is designed to … Continued
Survey: Medical Care During COVID
OCRA is conducting a survey to gauge patient response to the expansion of telehealth in response to the pandemic. Since the onset of the COVID-19 pandemic, telehealth has been growing in popularity. … Continued
The Overview: August 2021
As we count down to Ovarian Cancer Awareness Month and our virtual National Conference, there are so many ways to get involved … whether by learning more and connecting with … Continued
OCRA-Funded Research Reveals New Ovarian Cancer Biomarker and Growth Mechanisms
Researchers at UT Southwestern have discovered a potential “Achilles’ heel” in ovarian cancer cells, and a new biomarker that may open up more avenues for targeted therapies. The study, published … Continued
The Overview: July 2021
Sultry summer days can make anyone feel lazy and daydream of faraway places. But at OCRA, we’re working as hard as ever to fulfill our dream of a day when … Continued
OCRA’s Statement on the Introduction of HR 4412 to Reauthorize Johanna’s Law
Your Representative needs to hear from YOU. Please, urge your Representative to cosponsor Johanna’s Law today >> OCRA and the entire ovarian cancer community applaud the action taken on July … Continued
OCRA-Funded Study Identifies Antibiotic Found to Kill Tumor Cells Containing BRCA Mutations
A long-running study from Dana-Farber Cancer Institute, published in Nature Cancer and co-funded by OCRA, has discovered that the antibiotic novobiocin is capable of targeting and killing tumor cells in … Continued
OCRA’s Woman to Woman Peer Mentor Program Touted in Qualitative Study
Researchers from the University of Kansas School of Medicine conducted a study to capture the value and experience of giving and receiving peer support in the face of a gynecologic cancer diagnosis … Continued
Seeking New Insights Into Origins of Ovarian Cancer | Meet a Scientist
“It’s kind of like how the Apollo mission to the moon gave us Velcro.” Dr. David Chapel and his team are laying new groundwork in better understanding the origins of … Continued
Be #RareAware for Rare Ovarian Cancers
Many people are surprised to learn that ovarian cancer is not one disease, but several distinct types and subtypes. Each type differs in who it typically affects, how it spreads, … Continued